Vast Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
615 Davis Dr Ste 800, Morrisville, North...Phone Number
(919) 321-1375Website
www.vasttherapeutics.comRevenue
$6.4 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Vast Therapeutics
Vast Therapeutics is focused on developing breakthrough medicines for chronic respiratory diseases, aiming to improve the quality of life for patients suffering from conditions such as cystic fibrosis, bronchiectasis, and NTM lung disease. With a commitment to addressing the root causes of these debilitating conditions, the company is advancing its drug candidates through various stages of clinical development. Vast Therapeutics targets individuals affected by chronic lung diseases, which impact over 500 million people globally. Their mission is to reshape the future of respiratory medicine and help patients return to their daily activities.Explore more
Vast Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vast Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Vast Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Vast Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Vast Therapeutics launches new products
Vast Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Vast Therapeutics
Earning: See what the market has to say on Vast Therapeutics recently announced quarterly report
Check out if Vast Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Vast Therapeutics has new funding data
Recommended Actions
Reach out to Masked Content who joined Vast Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Vast Therapeutics
Compare insights from companies similar to Vast Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vast Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Vast Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Vast Therapeutics.
Vast Therapeutics financials insights
Gather financial insights about Vast Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$268K
Vast Therapeutics Tech Stack
A closer look at the technologies used by Vast Therapeutics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
New Hire
Executive Move
Funding
Vast Therapeutics News & Media
Vast Granted Qualified Infectious Disease Product Designation from the FDA
Advantages can accelerate making ALX1 drug candidate available to patients MORRISVILLE, N.C., March 25, 2025 /PRNewswire/ -- Vast Therapeutics, a clinical-stage life science company, today announced that the U.S. Food and Drug Administration has designated its ALX1 drug candidate as a...Vast Therapeutics Selected to Present at the American Thoracic Society (ATS) 2024 Respiratory Innovation Summit
MORRISVILLE, N.C., April 17, 2024 /PRNewswire/ -- Vast Therapeutics, a clinical-stage life science company focused on breaking the debilitating cycle of chronic infection and inflammation in respiratory diseases, today announced an upcoming presentation at the 2024 Respiratory Innovation...Vast Therapeutics Announces Publication of Potential New Treatment for Non-tuberculosis Mycobacteria Infections
Company targets novel inhaled therapies for drug-resistant chronic airway infections MORRISVILLE, N.C., Jan. 17, 2024 /PRNewswire/ -- Vast Therapeutics announces publication of a manuscript in the journal of Antimicrobial Agents & Chemotherapy describing the utility of its novel nitric...Vast Therapeutics Presents Promising Preclinical Results for Novel Treatment for NTM Disease
Company targets unmet medical need in millions of people around the world with drug resistant chronic airway infections DURHAM, N.C., July 1, 2022 /PRNewswire/ -- Vast Therapeutics announces promising results with a nitric oxide releasing drug candidate under investigation for infections...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Vast Therapeutics
Sign Up For FreeTo access detailed company insights
Vast Therapeutics is focused on developing breakthrough medicines for chronic respiratory diseases, aiming to improve the quality of life for patients suffering from conditions such as cystic fibrosis, bronchiectasis, and NTM lung disease. With a commitment to addressing the root causes of these debilitating conditions, the company is advancing its... Read More
